Conduit secures a composition of matter patent from the USPTO for its lead asset, AZD1656, a Glucokinase Activator targeting autoimmune disorders, positioning the Company for clinical development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback